Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | ALOX5AP | P20292 | 3/20 | 0.48 |
| ▸ | FEN1 | P39748 | 1/20 | 0.48 |
| ▸ | DPP4 | P27487 | 1/20 | 0.47 |
| ▸ | F2RL3 | Q96RI0 | 2/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.45 |
| ▸ | HRH2 | P25021 | 1/20 | 0.45 |
| ▸ | HRH1 | P35367 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6535308 | 1.00 | GPR119 (0.49) | GPR119ALDH1A1ALOX5APFEN1DPP4 | |
| SCHEMBL6535537 | 0.90 | GPR119 (0.49) | GPR119ALOX5APFEN1DPP4FFAR1 | |
| SCHEMBL14045135 | 0.90 | GPR119 (0.49) | GPR119ALOX5APFEN1DPP4FFAR1 | |
| SCHEMBL4314692 | 0.90 | GPR119 (0.49) | GPR119ALOX5APFEN1CHEK2HRH2 | |
| SCHEMBL2889380 | 0.90 | GPR119 (0.49) | GPR119ALOX5APFEN1CHEK2HRH2 | |
| SCHEMBL4326309 | 0.90 | GPR119 (0.49) | GPR119ALOX5APFEN1CHEK2HRH2 | |
| SCHEMBL604148 | 0.89 | FPR3 (0.51) | GPR119ALOX5APFEN1DPP4CHEK2 | |
| SCHEMBL6536147 | 0.89 | ALOX5AP (0.57) | GPR119ALDH1A1ALOX5AP | |
| SCHEMBL4312705 | 0.89 | GPR119 (0.48) | GPR119ALOX5APFEN1F2RL3CHEK2 | |
| SCHEMBL604147 | 0.89 | FPR3 (0.51) | GPR119ALOX5APFEN1DPP4CHEK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1242081-A4 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORP (US) | 2004-07-21 | — | — | EP | disclosed |
| EP-1001933-A4 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORP (US) | 2002-11-06 | — | — | EP | disclosed |
| EP-1242081-A1 | CASPASES AND APOPTOSIS | SmithKline Beecham Corporation (US) | 2002-09-25 | — | — | EP | disclosed |
| US-6403792-B1 | INHIBIT PRODUCTION OF CASPASE 3 AND 7 IN MAMMALS | SMITHKLINE BEECHAM CORPORATION | 2002-06-11 | — | — | US | disclosed |
| WO-2001022966-A1 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-04-05 | — | — | WO | disclosed |
| EP-1001933-A1 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999006367-A1 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-02-11 | — | — | WO | disclosed |